Literature DB >> 16433732

Measuring craving: an attempt to connect subjective craving with cue reactivity.

Wendy Ooteman1, Maarten W J Koeter, Roel Vserheul, Gerard M Schippers, Wim van den Brink.   

Abstract

BACKGROUND: Better insight into craving may contribute to the development of more efficient relapse prevention strategies. Inconsistent findings on the relation between craving and relapse may be due to difficulties in the measurement of craving. These difficulties are accounted for by 3 interrelated problems: lack of consensus regarding the definition of craving, the use of different time frames (craving now vs craving in the past), and lack of concordance between self-reported craving and psychophysiological measures of cue reactivity. The aim of this study is to develop and validate a new self-report questionnaire for the assessment of the core aspects of craving, taking into account different time frames and emphasizing the psychophysiological aspects of craving. It is hypothesized that this questionnaire will show higher concordance with measures of cue reactivity than existing self-report craving questionnaires.
METHODS: Based on a semantic mapping sentence, a 24-item self-report questionnaire was developed: the Jellinek Alcohol Craving Questionnaire (JACQ). The questionnaire was tested in 2 samples of treatment-seeking alcohol-dependent patients (sample A, n = 251; sample B, n = 48). Psychometric properties were examined in sample A and cross-validated in sample B. The associations with psychophysiological and neuroendocrine measures of cue reactivity were studied in sample B.
RESULTS: The JACQ consists of 1 dimension with the following 4 aspects: (1) emotional urge, (2) physical sensations, (3) temptation to drink, and (4) uncontrolled thoughts. All (sub)scales had a good internal consistency (alpha = 0.77-0.95) and were highly intercorrelated (r = 0.57-0.86). Craving-past correlated low with craving-now (r = 0.32). Craving-now (sub)scales showed a moderate association with heart rate (0.46-0.49), but not with respiration rate, skin conductance, or cortisol production in saliva following cue exposure. In contrast, craving-past (sub)scales showed a moderate association with cortisol production in saliva (0.15-0.42) following cue exposure. Remarkably, the physical symptoms scale did not show stronger association with psychophysiological and neuroendocrine measures than the other subscales.
CONCLUSIONS: The JACQ reliably measures 1 dimension including 4 aspects of craving for distinct time frames. Despite the presence of a special subscale for physical sensations, only moderate relationships were found between self-reported craving and biological indicators of cue reactivity. These findings suggest individual differences between alcoholics in the detection and/or reporting of cue-related psychophysiological signs as indicators of cue reactivity. Further research should focus on the nature of these individual differences. In addition, more research is needed on the relative predictive validity of subjective phenotypic indicators of craving (such as self-reported craving) versus objective endophenotypic indicators of craving (such as physiological measures of cue reactivity) for example in the prediction of relapse.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433732     DOI: 10.1111/j.1530-0277.2006.00019.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  26 in total

1.  Methamphetamine craving induced in an online virtual reality environment.

Authors:  Christopher Culbertson; Sam Nicolas; Itay Zaharovits; Edythe D London; Richard De La Garza; Arthur L Brody; Thomas F Newton
Journal:  Pharmacol Biochem Behav       Date:  2010-07-17       Impact factor: 3.533

Review 2.  A systematic review of the relationships between craving and smoking cessation.

Authors:  Jennifer M Wray; Julie C Gass; Stephen T Tiffany
Journal:  Nicotine Tob Res       Date:  2013-01-04       Impact factor: 4.244

3.  Self-reports of interoceptive responses during stress and drug cue-related experiences in cocaine- and alcohol-dependent individuals.

Authors:  Keri L Bergquist; Helen C Fox; Rajita Sinha
Journal:  Exp Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.157

4.  Effects of experimental pain induction on alcohol urge, intention to consume alcohol, and alcohol demand.

Authors:  Dezarie Moskal; Stephen A Maisto; Martin De Vita; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2018-01-11       Impact factor: 3.157

5.  Markers of abuse liability of short- vs long-acting opioids in chronic pain patients: a randomized cross-over trial.

Authors:  Barth L Wilsey; Scott Fishman; Chin-Shang Li; Jeanna Storment; Anthony Albanese
Journal:  Pharmacol Biochem Behav       Date:  2009-08-04       Impact factor: 3.533

6.  Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving.

Authors:  Zhen-Yu Ren; Jie Shi; David H Epstein; Jun Wang; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2009-01-27       Impact factor: 4.530

7.  Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin.

Authors:  Barbara J Mason; John M Light; Lauren D Williams; David J Drobes
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

Review 8.  Pharmacological approaches to reducing craving in patients with alcohol use disorders.

Authors:  Carolina L Haass-Koffler; Lorenzo Leggio; George A Kenna
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

9.  Evaluation of the Alcohol Craving Questionnaire-Now factor structures: application of a cue reactivity paradigm.

Authors:  Kevin M Connolly; Scott F Coffey; Joseph S Baschnagel; David J Drobes; Michael E Saladin
Journal:  Drug Alcohol Depend       Date:  2009-05-06       Impact factor: 4.492

10.  Tetrodotoxin reduces cue-induced drug craving and anxiety in abstinent heroin addicts.

Authors:  Jie Shi; Ting-Ting Liu; Xi Wang; David H Epstein; Li-Yan Zhao; Xiao-Li Zhang; Lin Lu
Journal:  Pharmacol Biochem Behav       Date:  2009-03-05       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.